Skip to main content
PMC home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1963 Jul;42(7):1040–1047. doi: 10.1172/JCI104789

THE SURVIVAL OF FACTOR VIII (ANTIHEMOPHILIC GLOBULIN) AND FACTOR IX (PLASMA THROMBOPLASTIN COMPONENT) IN NORMAL HUMANS*

Edward Adelson 1, Jack J Rheingold 1, Olive Parker 1, Manfred Steiner 1, James C Kirby 1
PMCID: PMC289372  PMID: 14011051

Full text

PDF
1040

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. AAS K. A., GARDNER F. H. Survival of blood platelets labeled with chromium. J Clin Invest. 1958 Sep;37(9):1257–1268. doi: 10.1172/JCI103713. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. ADELSON E., RHEINGOLD J. J., CROSBY W. H. Studies of platelet survival by tagging in vivo with p32. J Lab Clin Med. 1957 Oct;50(4):570–576. [PubMed] [Google Scholar]
  3. ADELSON E., RHEINGOLD J. J., PARKER O., BUENAVENTURA A., CROSBY W. H. Platelet and fibrinogen survival in normal and abnormal states of coagulation. Blood. 1961 Mar;17:267–281. [PubMed] [Google Scholar]
  4. ADELSON E., RHEINGOLD J. J., PARKER O. Platelet and fibrinogen sequestration. Blood. 1960 May;15:596–605. [PubMed] [Google Scholar]
  5. AGGELER P. M. Physiological basis for transfusion therapy in hemorrhagic disorders: a critical review. Transfusion. 1961 Mar-Apr;1:71–86. doi: 10.1111/j.1537-2995.1961.tb00017.x. [DOI] [PubMed] [Google Scholar]
  6. BALDINI M., COSTEA N., DAMESHEK W. The viability of stored human platelets. Blood. 1960 Dec;16:1669–1692. [PubMed] [Google Scholar]
  7. BARKHAN P. Christmas-factor activity of cord blood. Br J Haematol. 1957 Apr;3(2):215–219. doi: 10.1111/j.1365-2141.1957.tb05788.x. [DOI] [PubMed] [Google Scholar]
  8. BERMAN M., SHAHN E., WEISS M. F. The routine fitting of kinetic data to models: a mathematical formalism for digital computers. Biophys J. 1962 May;2:275–287. doi: 10.1016/s0006-3495(62)86855-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. BERMAN M., WEISS M. F., SHAHN E. Some formal approaches to the analysis of kinetic data in terms of linear compartmental systems. Biophys J. 1962 May;2:289–316. doi: 10.1016/s0006-3495(62)86856-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. COHEN J. A., LEEKSMA C. H. Determination of the life span of human blood platelets using labelled diisopropylfluorophosphonate. J Clin Invest. 1956 Sep;35(9):964–969. doi: 10.1172/JCI103356. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. DIDISHEIM P., LEWIS J. H. Production of anti-human PTC and anti-human proconvertin in rabbits. Proc Soc Exp Biol Med. 1956 Dec;93(3):429–432. doi: 10.3181/00379727-93-22778. [DOI] [PubMed] [Google Scholar]
  12. DIXON F. J., BUKANTZ S. C., DAMMIN G. J. The effect of sensitization and x-radiation on the metabolism of I131 labeled proteins. Science. 1951 Mar 9;113(2932):274–276. doi: 10.1126/science.113.2932.274. [DOI] [PubMed] [Google Scholar]
  13. GITLIN D., LATTA H., BATCHELOR W. H., JANEWAY C. A., CUSHMAN M., MARX K. Experimental hypersensitivity in the rabbit; disappearance rates of native and labelled heterologous proteins from the serum after intravenous injection. J Immunol. 1951 Apr;66(4):451–461. [PubMed] [Google Scholar]
  14. HAMMOND J. D., VEREL D. Observations on the distribution and biological half-life of human fibrinogen. Br J Haematol. 1959 Oct;5:431–438. doi: 10.1111/j.1365-2141.1959.tb04053.x. [DOI] [PubMed] [Google Scholar]
  15. HOAG M., AGGELER P. M., FOWELL A. H. Disappearance rate of concentrated proconvertin extracts in congenital and acquired hypoproconvertinemia. J Clin Invest. 1960 Mar;39:554–563. doi: 10.1172/JCI104068. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. MADDEN R. E., GOULD R. G. The turnover rate of fibrinogen in the dog. J Biol Chem. 1952 May;196(2):641–650. [PubMed] [Google Scholar]
  17. SCHULTZE B. Biologische Halbwertszeit einzelner Globulin-Fraktionen beim Kaninchen. Biochem Z. 1957;329(2):144–154. [PubMed] [Google Scholar]
  18. SCHULTZE B., MAURER W. Uber im Organismus des Kaninchens nach Injektion von S35-beta- und gamma-Globulinen entstehende S35-Albumine. Biochem Z. 1957;329(2):127–143. [PubMed] [Google Scholar]
  19. SPAET T. H., KINSELL B. G. Properties of bovine anti-hemophilic factor. Proc Soc Exp Biol Med. 1953 Nov;84(2):314–317. doi: 10.3181/00379727-84-20631. [DOI] [PubMed] [Google Scholar]
  20. STERLING K. The turnover rate of serum albumin in man as measured by I131-tagged albumin. J Clin Invest. 1951 Nov;30(11):1228–1237. doi: 10.1172/JCI102542. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. VOLWILER W., GOLDSWORTHY P. D., MACMARTIN M. P., WOOD P. A., MACKAY I. R., FREMONT-SMITH K. Biosynthetic determination with radioactive sulfur of turn-over rates of various plasma proteins in normal and cirrhotic man. J Clin Invest. 1955 Jul;34(7 Pt 1):1126–1146. doi: 10.1172/JCI103162. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. WAGNER R. H., LANGDELL R. D., RICHARDSON B. A., FARRELL R. A., BRINKHOUS K. M. Antihemophilic factor (AHF): plasma levels after administration of AHF preparations to hemophilic dogs. Proc Soc Exp Biol Med. 1957 Oct;96(1):152–155. doi: 10.3181/00379727-96-23417. [DOI] [PubMed] [Google Scholar]
  23. WASSERMAN K., MAYERSON H. S. Exchange of albumin between plasma and lymph. Am J Physiol. 1951 Apr 1;165(1):15–26. doi: 10.1152/ajplegacy.1951.165.1.15. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES